A.M.H. v. Purdue Pharma L.P. et al
| C. E., ON BEHALF OF THEMSELVES AND ALL OTHERS SIMILARLY SITUATED, A. M. H., INDIVIDUALLY AND IN HER CAPACITY AS LEGAL CUSTODIAN OF BABY C.E. and A.M.H. |
| McKesson Corporation, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., PURDUE PHARMA L.P., PURDUE PHARMA, INC., TEVA PHARMACEUTICAL INDUSTRIES, LTD., WATSON PHARMACEUTICALS, INC. n/k/a ACTAVIS, INC., Teva Pharmaceuticals USA, Inc., Endo Pharmaceuticals Inc., ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. n/k/a JANSSEN PHARMACEUTICALS, INC., Actavis LLC, Cardinal Health, Inc., ALLERGAN PLC f/k/a ACTAVIS PLC, The Purdue Frederick Company, Inc., WATSON LABORATORIES, INC., Cephalon, Inc., JANSSEN PHARMACEUTICA INC. n/k/a JANSSEN PHARMACEUTICALS, INC., Endo Health Solutions Inc., Johnson & Johnson, Janssen Pharmaceuticals, Inc., AMERISOURCEBERGEN CORPORATION, Janssen Pharmaceutica Inc., Insys Therapeutics, Inc., Allergan PLC, Actavis Pharma, Inc., Watson Pharmaceuticals, Inc. and Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
| 1:2018cv01018 |
| September 14, 2018 |
| US District Court for the Western District of New York |
| Elizabeth A Wolford |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1441 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 30, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 22 TEXT ORDER re #20 Motion to Strike, #21 Motion for Leave to File Supplemental Material. Responses are due on or before November 20, 2018. Replies are due on or before November 27, 2018. Upon receipt of all papers the Court will determine if oral argument is necessary and, if so, will inform the parties of the date and time. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 10/30/2018.(CDH) |
| E-Filing Notification: Modified relief re #21 MOTION for Leave to File (SG) |
| Filing 21 MOTION for leave to file supplemental material in further support of #20 MOTION to Strike by A.M.H.. (Attachments: #1 Affidavit, #2 Exhibit, #3 Exhibit)(Creadore, Donald) Modified on 10/30/2018 (SG). |
| Filing 20 MOTION to Strike #17 Memorandum in Opposition to Motion to the extent that Endo seeks court relief in the form of a stay by A.M.H.. (Attachments: #1 Affidavit, #2 Exhibit, #3 Exhibit, #4 Memorandum in Support)(Creadore, Donald) |
| Filing 19 *Disregard - Document re-filed at #20 with all attachments* First MOTION to Strike #17 Memorandum in Opposition to Motion seeking relief of stay by A.M.H..(Creadore, Donald) Modified on 10/22/2018 (KLH). |
| Filing 18 REPLY to Response to Motion re #5 MOTION to Remand filed by A.M.H.. (Creadore, Donald) |
| Filing 17 MEMORANDUM in Opposition re #5 MOTION to Remand filed by Endo Pharmaceuticals Inc.. (Rothman, Alan) |
| Pro Hac Vice fee: for Victor Cobb, Stephen Wussow and Celeste Brustowicz, $450.00, receipt number 61727 (SG) |
| Filing 16 TEXT ORDER granting #13 Motion to Appear Pro Hac Vice by Victor Cobb; #14 Motion to Appear Pro Hac Vice by Stephen Wussow; #15 Motion to Appear Pro Hac Vice by Celeste Brustowicz. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 10/09/2018. (CDH). -CLERK TO FOLLOW UP- |
| Verified admissions to the Louisiana State Bar for Attorneys Victor Cobb, Stephen Wussow, and Celeste Brustowicz. (NRE) |
| Filing 15 MOTION for Celeste Brustowicz to appear pro hac vice by A.M.H.(SG) |
| Filing 14 MOTION for Stephen Wussow to appear pro hac vice by A.M.H.(SG) |
| Filing 13 MOTION for Victor Cobb to appear pro hac vice by A.M.H.(SG) |
| Filing 12 Corporate Disclosure Statement by Endo Health Solutions Inc. identifying Corporate Parent Endo International plc for Endo Health Solutions Inc... (Rothman, Alan) |
| Filing 11 Corporate Disclosure Statement by Purdue Pharma L.P., Purdue Pharma, Inc., The Purdue Frederick Company, Inc. identifying Corporate Parent Pharmaceutical Research Associates, Inc. for The Purdue Frederick Company, Inc.; Corporate Parent No Parent Corporation for Purdue Pharma L.P., Purdue Pharma, Inc... (Cusker Gonzalez, Mara) |
| Filing 10 TEXT ORDER granting #4 Consent Motion for Extension of Time to File Answer. The moving parties' deadline to answer or otherwise respond to the Complaint is extended to the later of 30 days after (1) the Court's ruling on the pending motion to remand or (2) the entry of a decision by the Judicial Panel on Multidistict Litigation granting a motion to vacate a conditional transfer order covering this action (or otherwise finally denying transfer of this action to the multi-district litigation). SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 09/26/2018. (CDH) |
| Filing 9 Corporate Disclosure Statement by AmerisourceBergen Corporation identifying Corporate Parent Walgreens Boots Alliance Holdings LLC for AmerisourceBergen Corporation.. (Asfendis, Paul) |
| Filing 7 AFFIDAVIT of Service for Notice of Motion, Affirmation in Support and Memo of Law served on All defense counsel on 09/24/2018, filed by A.M.H.. (Creadore, Donald) |
| Filing 6 TEXT ORDER re #5 Motion to remand. Responses due on or before October 15, 2018. Replies due on or before October 22, 2018. Upon receipt of all papers the Court will determine if oral argument is necessary and, if so, will inform the parties of the date and time. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 09/24/2018. (CDH) |
| Filing 5 MOTION to Remand by A.M.H.. (Attachments: #1 Exhibit Affidavit in Support, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G, #9 Exhibit H, #10 Exhibit I, #11 Exhibit J, #12 Memorandum in Support Memo in Support)(Creadore, Donald) |
| ATTENTION CORPORATION PLAINTIFFS/DEFENDANTS: All Corporate Disclosure Statements pursuant to Fed.R.Civ.7.1(b) are to be filed within seven(7) days of this notice. (MD) |
Filing 8
ORDER granting #3 Motion for Extension of Time to Answer. Signed by Hon. Elizabeth A. Wolford on 9/21/18. (SG)
|
| Filing 4 Consent MOTION for Extension of Time to File Answer Manufacturer Defendants Consent Motion for Extension of Time to Respond to Plaintiffs Complaint by Endo Health Solutions Inc., Endo Pharmaceuticals Inc.. (Attachments: #1 Text of Proposed Order)(Rothman, Alan) |
| Filing 3 MOTION for Extension of Time to File Answer re #1 Notice of Removal, Letter Motion by AmerisourceBergen Corporation, Cardinal Health, Inc., McKesson Corporation.(Asfendis, Paul) |
| Case assigned to Hon. Elizabeth A. Wolford. Notification to Chambers of on-line civil case opening. (SG) |
| AUTOMATIC REFERRAL to Mediation The ADR Plan is available for download at http://www.nywd.uscourts.gov/alternative-dispute-resolution(SG) |
| Notice of Availability of Magistrate Judge: A United States Magistrate of this Court is available to conduct all proceedings in this civil action in accordance with 28 U.S.C. 636c and FRCP 73. The Notice, Consent, and Reference of a Civil Action to a Magistrate Judge form (AO-85) is available for download at http://www.uscourts.gov/services-forms/forms. (SG) |
| Filing 2 Corporate Disclosure Statement by Endo Pharmaceuticals Inc. identifying Corporate Parent Endo International plc for Endo Pharmaceuticals Inc... (Rothman, Alan) |
| Filing 1 NOTICE OF REMOVAL by Endo Pharmaceuticals Inc. (Filing fee $ 400 receipt number 0209-3220573) from Supreme Court of the State of New York, Niagara County, case number E165792/2018., filed by Endo Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1 to Notice of Removal, #2 Exhibit 2 to Notice of Removal, #3 Exhibit 3 - State Court Documents, #4 Civil Cover Sheet)(Rothman, Alan) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
